Ter Meulen J - Search Results

1

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors.

Albershardt TC, Leleux J, Parsons AJ, Krull JE, Berglund P, Ter Meulen J. Albershardt TC, et al. Among authors: ter meulen j. NPJ Vaccines. 2020 Jun 16;5(1):50. doi: 10.1038/s41541-020-0201-x. eCollection 2020. NPJ Vaccines. 2020. PMID: 32579133 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 33580087

3

Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory.

Leleux JA, Albershardt TC, Reeves R, James R, Krull J, Parsons AJ, Ter Meulen J, Berglund P. Leleux JA, et al. Among authors: ter meulen j. PLoS One. 2021 Dec 2;16(12):e0259301. doi: 10.1371/journal.pone.0259301. eCollection 2021. PLoS One. 2021. PMID: 34855754 Free PMC article.

4

LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response.

Albershardt TC, Campbell DJ, Parsons AJ, Slough MM, Ter Meulen J, Berglund P. Albershardt TC, et al. Among authors: ter meulen j. Mol Ther Oncolytics. 2016 Mar 30;3:16010. doi: 10.1038/mto.2016.10. eCollection 2016. Mol Ther Oncolytics. 2016. PMID: 27626061 Free PMC article.

5

Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine.

Albershardt TC, Parsons AJ, Reeves RS, Flynn PA, Campbell DJ, Ter Meulen J, Berglund P. Albershardt TC, et al. Among authors: ter meulen j. Vaccine. 2020 Apr 9;38(17):3369-3377. doi: 10.1016/j.vaccine.2020.02.034. Epub 2020 Feb 20. Vaccine. 2020. PMID: 32088020

6

ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities.

Leleux JA, Albershardt TC, Parsons AJ, Ter Meulen J, Berglund P. Leleux JA, et al. Among authors: ter meulen j. Vaccine. 2020 Sep 22;38(41):6367-6373. doi: 10.1016/j.vaccine.2020.08.003. Epub 2020 Aug 20. Vaccine. 2020. PMID: 32828576

7

HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.

Wee EG, Ondondo B, Berglund P, Archer J, McMichael AJ, Baltimore D, Ter Meulen JH, Hanke T. Wee EG, et al. Among authors: ter meulen jh. Mol Ther. 2017 Feb 1;25(2):494-503. doi: 10.1016/j.ymthe.2016.12.004. Mol Ther. 2017. PMID: 28153096 Free PMC article.

8

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A.

Lu H, Betancur A, Chen M, Ter Meulen JH. Lu H, et al. Among authors: ter meulen jh. Front Oncol. 2020 Aug 19;10:1438. doi: 10.3389/fonc.2020.01438. eCollection 2020. Front Oncol. 2020. PMID: 32974162 Free PMC article.

9

Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.

Pillet S, Aubin É, Trépanier S, Poulin JF, Yassine-Diab B, Ter Meulen J, Ward BJ, Landry N. Pillet S, et al. Among authors: ter meulen j. NPJ Vaccines. 2018 Jan 23;3:3. doi: 10.1038/s41541-017-0043-3. eCollection 2018. NPJ Vaccines. 2018. PMID: 29387473 Free PMC article.

10

Immune Design.

Ter Meulen J, Brady SR. Ter Meulen J, et al. Hum Vaccin Immunother. 2017 Jan 2;13(1):15-16. doi: 10.1080/21645515.2016.1239490. Epub 2016 Nov 21. Hum Vaccin Immunother. 2017. PMID: 27870594 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters